BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10701734)

  • 1. Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology.
    Hanlon AL; Hanks GE
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):559-66. PubMed ID: 10701734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.
    Horwitz EM; Uzzo RG; Hanlon AL; Greenberg RE; Hanks GE; Pollack A
    J Urol; 2003 Jun; 169(6):2153-7; discussion 2157-9. PubMed ID: 12771738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AL; Dong L; Kamat A; Pisters L; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):14-9. PubMed ID: 15629589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
    Thames H; Kuban D; Levy L; Horwitz EM; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):929-43. PubMed ID: 14575823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Kuban D; Thames H; Levy L; Horwitz E; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):409-14. PubMed ID: 15667960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
    Horwitz EM; Thames HD; Kuban DA; Levy LB; Kupelian PA; Martinez AA; Michalski JM; Pisansky TM; Sandler HM; Shipley WU; Zelefsky MJ; Hanks GE; Zietman AL
    J Urol; 2005 Mar; 173(3):797-802. PubMed ID: 15711272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of irregularly rising prostate-specific antigen and "impending failure" on the apparent outcome of localized prostate cancer following radiotherapy.
    Hodgson DC; Catton CN; Warde P; Gospodarowicz MK; Milosevic MF; McLean M B M; Catton P
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):957-63. PubMed ID: 11240236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions of biochemical failure in prostate cancer following radiation therapy.
    Taylor JM; Griffith KA; Sandler HM
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1212-9. PubMed ID: 11483331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
    Roach M; Hanks G; Thames H; Schellhammer P; Shipley WU; Sokol GH; Sandler H
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):965-74. PubMed ID: 16798415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
    Buyyounouski MK; Hanlon AL; Eisenberg DF; Horwitz EM; Feigenberg SJ; Uzzo RG; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1455-62. PubMed ID: 16169682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.
    Pickles T;
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1355-9. PubMed ID: 16406391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The definition of biochemical failure in patients treated with definitive radiotherapy.
    Kattan MW; Fearn PA; Leibel S; Potters L
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1469-74. PubMed ID: 11121650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?
    Amling CL; Bergstralh EJ; Blute ML; Slezak JM; Zincke H
    J Urol; 2001 Apr; 165(4):1146-51. PubMed ID: 11257657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis.
    Coen JJ; Chung CS; Shipley WU; Zietman AL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):621-8. PubMed ID: 14529765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
    Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
    Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure.
    Hanlon AL; Hanks GE
    Cancer J; 2000 Apr; 6 Suppl 2():S193-7. PubMed ID: 10803836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asians with localized prostate cancer treated with 3-dimensional conformal radiation therapy and adjuvant hormonal therapy: comparing Phoenix and American Society of Therapeutic Radiology and Oncology (ASTRO) definitions in an Asian population.
    Ramalingam M; Lau W; Tan T; Fook S; Ngoi F; Cheng C
    Urology; 2008 Mar; 71(3):506-10. PubMed ID: 18342198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer.
    Vicini FA; Kestin LL; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):553-61. PubMed ID: 10524405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
    Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.